Journal article · 2015
P.3.d.019 Lurasidone treatment response in patients with schizophrenia assessed using the DSM-5 dimensions of psychosis severity scale
European Neuropsychopharmacology, 25, S491 · Published 1 September 2015 · DOI 10.1016/s0924-977x(15)30671-4
In brief
“P.3.d.019 Lurasidone treatment response in patients with schizophrenia assessed using the DSM-5 dimensions of psychosis severity scale” is a 2015 journal article by Antony D Loebel and 6 co-authors, published in European Neuropsychopharmacology. OpenAlex counts 0 citations as of 20 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 0
- Authors
- 7
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Loebel, A. D., Schooler, N., Siu, C., Cucchiaro, J. B., Pikalov, A., Goldman, R., & Grossman, F. (2015). P.3.d.019 Lurasidone treatment response in patients with schizophrenia assessed using the DSM-5 dimensions of psychosis severity scale. European Neuropsychopharmacology, 25, S491. https://doi.org/10.1016/s0924-977x(15)30671-4
MLA 9
Loebel, Antony D, et al. “P.3.d.019 Lurasidone treatment response in patients with schizophrenia assessed using the DSM-5 dimensions of psychosis severity scale.” European Neuropsychopharmacology, vol. 25, 2015, p. S491. https://doi.org/10.1016/s0924-977x(15)30671-4.
Chicago
Loebel, Antony D, N. Schooler, C. Siu, Josephine B. Cucchiaro, Andrei Pikalov, R. Goldman, and F. Grossman. 2015. “P.3.d.019 Lurasidone treatment response in patients with schizophrenia assessed using the DSM-5 dimensions of psychosis severity scale.” European Neuropsychopharmacology 25: S491. https://doi.org/10.1016/s0924-977x(15)30671-4.
Harvard
Loebel, A. D. et al. (2015) ‘P.3.d.019 Lurasidone treatment response in patients with schizophrenia assessed using the DSM-5 dimensions of psychosis severity scale’, European Neuropsychopharmacology, 25, p. S491. doi:10.1016/s0924-977x(15)30671-4.
IEEE
A. D. Loebel et al., “P.3.d.019 Lurasidone treatment response in patients with schizophrenia assessed using the DSM-5 dimensions of psychosis severity scale,” European Neuropsychopharmacology, vol. 25, p. S491, 2015, doi: 10.1016/s0924-977x(15)30671-4.
BibTeX
@article{loebel2015lurasidone,
title = {{P.3.d.019 Lurasidone treatment response in patients with schizophrenia assessed using the DSM-5 dimensions of psychosis severity scale}},
author = {Loebel, Antony D and Schooler, N. and Siu, C. and Cucchiaro, Josephine B. and Pikalov, Andrei and Goldman, R. and Grossman, F.},
journal = {European Neuropsychopharmacology},
year = {2015},
volume = {25},
pages = {S491},
doi = {10.1016/s0924-977x(15)30671-4},
url = {https://doi.org/10.1016/s0924-977x(15)30671-4}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- lurasidone
- schizophrenia
- treatment response
- psychosis severity
- atypical antipsychotics
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Loebel, A. D., Schooler, N., Siu, C., Cucchiaro, J. B., Pikalov, A., Goldman, R., & Grossman, F. (2015). P.3.d.019 Lurasidone treatment response in patients with schizophrenia assessed using the DSM-5 dimensions of psychosis severity scale. European Neuropsychopharmacology, 25, S491. https://doi.org/10.1016/s0924-977x(15)30671-4
How many times has this paper been cited?
0 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Antony D Loebel, N. Schooler, C. Siu, Josephine B. Cucchiaro, Andrei Pikalov, R. Goldman, F. Grossman.
What is the DOI of this paper?
10.1016/s0924-977x(15)30671-4, permanently at https://doi.org/10.1016/s0924-977x(15)30671-4. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.